PBMT in Providing Temporary Relief of Low Back Pain of Musculoskeletal Origin

NCT06549660 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-09-04

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of PBMT for adjunctive use in providing temporary relief of minor chronic low back pain of musculoskeletal origin.

The main questions it aims to answer are:

(i) Is PBMT able to decrease pain intensity in patients with chronic low back pain of musculoskeletal origin? (ii) Is PBMT able to decrease disability in patients with chronic low back pain of musculoskeletal origin?

Researchers will compare active PBMT with placebo PBMT to see if active PBMT provides temporary relief of minor chronic low back pain of musculoskeletal origin.

Conditions

  • Low Back Pain

Interventions

DEVICE

Active PBMT

Active with a dose of 165 J per site, resulting in a total dose of 495J.

DEVICE

Placebo PBMT

Placebo, without therapeutic dose.

Sponsors & Collaborators

  • Multi Radiance Medical

    collaborator INDUSTRY
  • University of Nove de Julho

    lead OTHER

Principal Investigators

  • Ernesto Cesar Pinto Leal Junior, PhD · University of Nove de Julho

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-20
Primary Completion
2025-08-20
Completion
2025-10-01
FDA Device
Yes

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06549660 on ClinicalTrials.gov